An anti-inflammatory effect of Faecalibacterium prausnitzii, partially due to secreted metabolites able to block NF-kB activation and IL-8 production, was recently reported, and the potential of this specific microorganism as a probiotic for Crohn's disease treatment in humans was suggested [8]. Here, NFKB1 is linked to Crohn disease.